Zusammenfassung
MicroRNAs (miRNAs) sind kleine (20–24 Nukleotide), nichtkodierende Ribonukleinsäuren, die durch Regulation der Genexpression auf der posttranskriptionalen Ebene in physiologische Prozesse wie Wachstum, Differenzierung und Apoptose eingreifen. Insbesondere für das papilläre Schilddrüsenkarzinom wurde eine typische Überexpression mehrerer miRNAs (u. a. miRNA 146b, 221 und 222) gezeigt. Im vorliegenden Artikel werden die Möglichkeiten und Probleme der miRNA-Analyse an durch Feinnadelbiopsie gewonnenem Material aus Schilddrüsenknoten beschrieben und diskutiert. Insbesondere die Analyse von definierten Kombinationen von miRNAs sollte zu einer Steigerung der Aussagekraft dieser Methode und einem verbesserten Management der Patienten mit hypofunktionellen Schilddrüsenknoten führen.
Abstract
MicroRNAs (miRNAs) are small (20–24 nucleotides), non-coding ribonucleid acids, which regulate gene expression on the post-transcriptional level, thus influencing physiological processes including cellular growth, differentiation and apoptosis. Several miRNAs (e. g. miRNAs 146b, 221 and 222) have been shown to be consistently over-expressed in papillary thyroid carcinoma. The present overview describes and discusses the utilization and problems of miRNA analysis in material from thyroid nodules obtained by fine needle biopsy. Particularly the analysis of defined sets of miRNAs should improve the diagnostic value of this procedure and contribute to a better management of patients with cold thyroid nodules.
Literatur
Abraham D, Jackson N, Gundara JS et al (2011) MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets. Clin Cancer Res 17:4772–4781
Anonymous http://mirbase.org/cgi-bin/browse.pl?org=hsa
Bhaijee F, Nikiforov YE (2011) Molecular analysis of thyroid tumors. Endocr Pathol 22:126–133
Braun J, Huttelmaier S (2011) Pathogenic mechanisms of deregulated microRNA expression in thyroid carcinomas of follicular origin. Thyroid Res 4(Suppl 1):S1
Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857–866
Carney JA, Ryan J, Goellner JR (1987) Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 11:583–591
Chen Y, Kitabayashi N, Zhou X et al (2008) MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol 21:1139–1146
Ferraz C, Rehfeld C, Krogdahl A et al (2011) Detection of point mutations and rearrangements in routine air dried fine needle aspiration (FNA) smears. Thyroid 21:A-118
Geraldo MV, Yamashita AS, Kimura ET (2011) MicroRNA miR-146b-5p regulates signal transduction of TGF-beta by repressing SMAD4 in thyroid cancer. Oncogene 31:1910–1922
Gharib H, Papini E, Paschke R et al (2010) American association of clinical endocrinologists, associazione medici endocrinologi, and European thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 16(Suppl 1):1–43
Gharib H, Papini E, Valcavi R et al (2006) American association of clinical endocrinologists and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12:63–102
Karger S, Toetsch M, Krause K et al (2008) Thy thyroid nodule–differential diagnostics and treatment concepts. Med Klin (Munich) 103:575–588 (quiz 589–590)
Menon MP, Khan A (2009) Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications. J Clin Pathol 62:978–985
Musholt TJ, Clerici T, Dralle H et al (2011) German association of endocrine surgeons practice guidelines for the surgical treatment of benign thyroid disease. Langenbecks Arch Surg 396:639–649
Musholt TJ, Fottner C, Weber MM et al (2010) Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules. World J Surg 34:2595–2603
Nikiforova MN, Caudill CM, Biddinger P et al (2002) Prevalence of RET/PTC rearrangements in Hashimoto’s thyroiditis and papillary thyroid carcinomas. Int J Surg Pathol 10:15–22
Nikiforova MN, Nikiforov YE (2009) Molecular diagnostics and predictors in thyroid cancer. Thyroid 19:1351–1361
Nikiforova MN, Tseng GC, Steward D et al (2008) MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93:1600–1608
Ohori NP, Nikiforova MN, Schoedel KE et al (2010) Contribution of molecular testing to thyroid fine-needle aspiration cytology of „follicular lesion of undetermined significance/atypia of undetermined significance“. Cancer Cytopathol 118:17–23
Pallante P, Visone R, Ferracin M et al (2006) MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13:497–508
Paschke R, Schmid KW, Gartner R et al (2010) Epidemiology, pathophysiology, guideline-adjusted diagnostics, and treatment of thyroid nodules. Med Klin (Munich) 105:80–87
Sadow PM, Heinrich MC, Corless CL et al (2010) Absence of BRAF, NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas. Endocr Pathol 21:73–79
Schmid KW (2010) Molecular pathology of thyroid tumors. Pathologe 31(Suppl 2):229–233
Schmid KW (2012) Zytologie: Was bringt die Molekularpathologie? Henning-Symposium Schilddrüse 2011
Schmid KW, Reiners C (2011) Wann ist die Feinnadelbiopsie der Schilddrüse am effektivsten? Pathologe 32:169–172
Schwertheim S, Sheu SY, Worm K et al (2009) Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma. Horm Metab Res 41:475–481
Schwertheim S, Sheu SY, Worm K, Schmid KW (2012) Dysregulation of miRNA expression in normal thyroid tissue adjacent to tumor cells. 96. Jahrestagung der Deutschen Gesellschaft für Pathologie
Sheu SY, Grabellus F, Schwertheim S et al (2009) Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma. Horm Metab Res 41:482–487
Sheu SY, Grabellus F, Schwertheim S et al (2010) Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. Br J Cancer 102:376–382
Ting S, Bockisch A, Führer-Sakel D et al (2012) Feinnadelbiopsie (FNB) der Schilddrüse. Nuklearmed 35:22–29
Ting S, Puttinger C, Schmid KW et al (2011) Der hyalinisierende trabekuläre Tumor der Schilddrüse. Eine übertrieben vorsichtige Bezeichnung für einen gutartigen Tumor? Pathologe 33:135–141
Visone R, Pallante P, Vecchione A et al (2007) Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26:7590–7595
Volante M, Collini P, Nikiforov YE et al (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256–1264
Interessenkonflikt
Der korrespondierende Autor erklärt für sich und seine Koautoren, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ting, S., Sheu-Grabellus, SY., Worm, K. et al. MicroRNA-Profile in der Feinnadelbiopsie der Schilddrüse. Pathologe 33, 331–336 (2012). https://doi.org/10.1007/s00292-012-1581-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00292-012-1581-0